To establish health through periodontal intervention per JP Institute protocols.
Additional Comments: The post therapy test was ordered as an Alert 2™. Nutritional Counseling was also administered.
By incorporating OralDNA salivary tests, the pre-test MyPerioPath, and integrating The JP Institute methods of communication, my patient was able to own her disease. The pre MyPerioPath confirms a bacterial cause and the post MyPerioProgress gives an objective measurement of bacteria reduction. The MyPerioID® portion of the Alert 2 being G/G, or High risk, helps to establish the need for more comprehensive non-surgical therapy and frequent re-care as well as forewarns the patient of possible relapse.
I was confident the periodontal therapy was going to result in a healthy tissue response, which is apparent from the below photo. The patient and I were pleasantly surprised with the overall health benefits including improved energy, better breathing- as her sinuses cleared resulting in secession of mouth breathing, and her mood stabilized resulting in discontinuation of Adderall.
Annie-Laurie Harris BSDH, RDHMP has been in clinical practice for 22 years. Her career began in a progressive periodontal specialty practice where she developed a fascination for the treatment and maintenance of periodontal disease. She was introduced to a philosophy and technique that was innovative and successful in treating periodontal disease. She received intensive training from the JP Institute in Evolutionary Hygiene in 2004. In 2008 she completed JP Institute's Mastership program. She is also currently pursuing a Master's Degree in Dental Hygiene Research at Old Dominion University.
She became a founding member of the American Academy of Oral Systemic Health. This discovery ignited an enthusiasm for the science and treatment of biofilm. Her colleagues and patients have given her the affectionate nick-name 'Dental Geek'. She has been known to attach a head cam to demonstrate (to her willing patients) live video of the biofilm disruption process. Annie is thrilled to be mentoring and training to her fellow colleagues and considers herself a JP Institute Evangelist.
To establish periodontal remission by addressing the clinical manifestations of periodontal disease and altering the oral flora in order to lower the incidence of periodontal disease relapse. Bacterial management will eliminate a source of total body inflammation and increase success of implant placement.
Additional Comments: Patient indicates he visits the dentist every six months and reports no previous periodontal treatment.
Clinically there was 100% pocket size reduction on pockets greater than 3mm. All periodontal pockets stabilized and zero bleeding on probing was observed. There was a 79% reduction in periodontal pathogen (burden) load 3 months and 18 days after treatment started. These current results are likely associated with a decrease in both oral and systemic inflammation. Having clinical improvement is always our goal and was achieved in this case. The significance of having the pre and post therapy MyPerioPath results gives me an objective measurement to things I can’t visually see. With the reduction of bacterial load, I now know the environment for surgical placement of an implant has less risk for failure due to periodontal pathogens. I utilize this test as a pre-surgical work up, just like a medical doctor uses blood work before their hip/knee/valve replacements surgeries.
Dr. Patricia Lugo is a Puertorriquena oral surgeon who studied her doctorate degree at University of Puerto Rico Medical Sciences Campus and has been practicing for more than 10 years in the private sector. Her passion is practicing Complete Health Dentistry, dentistry that links oral health with systemic health. She works with her husband, Dr. Edwin Rodriguez, prosthodontist, on providing optimal health to patients with complex oral rehabilitations.
To reduce periodontal pathogens, a significant cause for the periodontal inflammation and halitosis.
Clinically there was a significant decrease in bleeding on probing and pocket depth reduction was amazing. The MyPerioProgress showed pathogen reduction from 8 above reference line to 0. I enjoy seeing the patient’s reaction when they realize they have some control over what is happening. When they do the expected increased home care and reduce therapy time, they are thrilled. This re-enforces home care for maintenance. In this case, the patient’s partner was tested and revealed periodontal pathogens very similar to this patient, however the partner has refused treatment at this time. This places our patient at risk for relapse especially due to the Celsus One results.
The patient has Class II periodontitis with a lack of home care and recall. Through periodontal therapy, our goal is to establish a remission of the disease and establish a healthier bacterial load to reduce oral/systemic complications. Through education, our goal is to establish home care habits to assist patient’s remission and stress the need for recall not just for health of periodontium but overall health.
At the 6-week tissue check, this patient has been using an electric toothbrush 1-2x per day, flossing a couple times per week, utilizing a tongue scraper, and using the chlorhexidine mouth rinse. Patient discontinued the rinse after 2 weeks due to increasing sensitivity. Post-therapy periodontal charting was completed with 1 localized 4mm residual pocketing and 12 out of 168 bleeding on probing. The post therapy MyPerioPath saliva sample was collected. A prophy, polishing, flossing was also completed. Patient will be seen every 3 months for periodontal maintenance. MyPerioProgress results showed reduced periodontal pathogens reductions from 7 pathogens above reference lines to 0 above. The patient was called, and results were reviewed, she then received a copy to give to her medical doctor.